Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 128 | 128 | 738 | 737 | 2,213 |
| Gross Profit | 128 | 128 | 738 | 737 | 2,213 |
| Operating Expenses | 4,917 | 4,682 | 4,375 | 2,731 | -13,510 |
| Operating Income | -4,789 | -4,554 | -3,637 | -1,994 | 15,723 |
| Interest Expense | 76 | 75 | 1 | 0 | 0 |
| Other Income | 343 | 6,755 | 40 | 5 | -198 |
| Pre-tax Income | -4,522 | 2,126 | -3,598 | -1,989 | 15,525 |
| Income Tax | -196 | -4 | N/A | N/A | N/A |
| Net Income Continuous | -4,326 | 2,130 | -3,598 | -1,989 | 15,459 |
| Net Income | $-4,326 | $2,130 | $-3,598 | $-1,989 | $15,459 |
| EPS Basic Total Ops | 7.23 | 0.20 | -5.40 | -3.23 | 2.67 |
| EPS Basic Continuous Ops | 7.23 | 0.20 | -5.40 | -3.23 | 2.65 |
| EPS Diluted Total Ops | 7.25 | 0.18 | -5.40 | -3.23 | 2.67 |
| EPS Diluted Continuous Ops | 7.25 | 0.18 | -5.40 | -3.23 | 2.65 |
| EBITDA(a) | $-4,713 | $-4,490 | $-3,582 | $-1,948 | $15,762 |